ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01656525
Recruitment Status : Completed
First Posted : August 3, 2012
Last Update Posted : September 19, 2014
Sponsor:
Information provided by (Responsible Party):
Chugai Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2014
  Actual Study Completion Date : June 2014